Occlutech - a leader in structural heart disease therapies

 AFR for Heart Failure

The Atrial Flow Regulator (AFR) is a transcatheter cardiac implant, designed for use in patients with heart failure (either HFpEF or HFrEF) who continue to experience worsening symptoms despite optimal medical therapy.

The AFR reduces the pressure in the left side of the heart by maintaining a controlled interatrial septal shunt between the left and right atrium. The procedure is minmally invasive and initial results show a 100% success with the device1.


 Our products

Occlutech creates products that can be implanted in a high rate of patients, avoiding surgery, while minimizing potentially fatal complications. With around 100,000 implants, Occlutech has a product performance track record and experience of more than 15 years. 

Occlutech occluders


We are looking for highly motivated individuals inspired by making a difference in patients’ lives to join our dynamic teams.
Content references:
  1. https://pubmed.ncbi.nlm.nih.gov/31130524/